GlassScriptPhysician profile
Olivia E Mancilla
NPI 1467842427
$2,357.72
in general payments reported to CMS, 2019-2025
10 companies · $491 in 2025
The $491 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $301 · 2022: $296 · 2023: $407 · 2024: $863 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,760.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,389.32 | 2022-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Ultreon |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $355.10 | 2021-2024 | Lifevest |
| Kestra Medical Technology Services, INC. | $170.92 | 2023-2025 | Assure Wcd |
| Abiomed | $94.38 | 2024-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $90.77 | 2021-2022 | |
| Amgen INC. | $82.55 | 2021-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $78.36 | 2021-2024 | Xarelto |
| Pfizer INC. | $52.54 | 2021-2024 | |
| Solventum Corporation | $26.89 | 2024 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Lantheus Medical Imaging, INC. | $16.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Mancilla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.